Etilevodopa
From Wikipedia, the free encyclopedia
Jump to: navigation, search
![]() |
|
![]() |
|
Clinical data | |
---|---|
ATC code | N04BA06 (WHO) (combination with decarboxylase inhibitor) |
Identifiers | |
Systematic (IUPAC) name: ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate
|
|
CAS Number | 37178-37-3 ![]() |
PubChem (CID) | 170345 |
ChemSpider | 148944 ![]() |
UNII | 895X917GYE ![]() |
KEGG | D04097 ![]() |
Chemical and physical data | |
Formula | C11H15NO4 |
Molar mass | 225.241 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Etilevodopa (TV-1203) is a dopaminergic agent which was developed as a treatment for Parkinson's disease.[1] It is the ethyl ester of levodopa. It was never marketed.
See also[edit]
References[edit]
- ^ Djaldetti Ruth; Giladi Nir; Hassin-Baer Sharon; Shabtai Hertzel; Melamed Eldad (November–December 2003). "Pharmacokinetics of Etilevodopa Compared to Levodopa in Patient's With Parkinson's Disease: An Open-label, Randomized, Crossover Study". Clinical Neuropharmacology. 26 (6): 322–326. doi:10.1097/00002826-200311000-00012.
Dopaminergics |
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anticholinergics | |||||||||||||||||||
Others | |||||||||||||||||||
|
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |